Europe and Northern America vs Sweden: Proportion of the target population who received the final dose of
Europe and Northern America
46.0%
in 2024
Sweden
87.0%
in 2024
Europe and Northern America rank
16th
Sweden rank
16th
Proportion of the target population who received the final dose of over time
- Europe and Northern America
- Sweden
How they compare
Sweden currently reports 87.0% against 46.0% in Europe and Northern America, a difference of 41.0%.
That makes Sweden's figure about 1.9 times Europe and Northern America's.
Across all 9 years both countries report, Sweden has been ahead every year.
Europe and Northern America ranks 16th and Sweden ranks 16th of 35 groups.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe and Northern America | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.2% | 75.0% | 36.8% | Sweden |
| 2020s | 43.6% | 85.6% | 42.0% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Europe and Northern America or Sweden?
- Sweden, at 87.0% against 46.0% in Europe and Northern America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Europe and Northern America and Sweden?
- 41.0%, with Sweden ahead.
- How many years of comparable data are there for Europe and Northern America and Sweden?
- 9 years are reported by both, from 2016 to 2024.
- How do Europe and Northern America and Sweden rank globally for proportion of the target population who received the final dose of?
- Europe and Northern America ranks 16th and Sweden ranks 16th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.